CLINICAL_TRIALS
trial_result
· 2026-01-20
Clinical Trial Update: the Safety, Tolerability and Pharmacokinetics of Mulberry Twig Alkaloids in Human [Phase 1]
Summary
A Phase 1 trial evaluated the safety, tolerability, and pharmacokinetics of mulberry twig alkaloids in humans, including participants with overweight or obesity…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Wehand-Bio Pharmaceutical Co., Ltd | Conditions: Overweight and Obesity, Healthy | Phase 1 | Status: COMPLETED